Legal Representation
Attorney
Wendy E. Miller
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 23, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 21, 2003 | I | PAPER RECEIVED | Loading... | |
| Jan 17, 2003 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 17, 2003 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Aug 14, 2002 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 22, 2002 | I | PAPER RECEIVED | Loading... | |
| Jul 17, 2002 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 8, 2002 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 17, 2002 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 11, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 7, 2001 | REIN | O | REINSTATED | Loading... |
| Jul 18, 2001 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 10, 2001 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 2, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 18, 2001 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 18, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Feb 8, 2000 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jan 11, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 10, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Oct 15, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 30, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 29, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 11, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
PHARMACEUTICAL PREPARATIONS FOR DELIVERING THERAPEUTIC AND VACCINE TREATMENTS THROUGH THE BODY, FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES, NAMELY, DIABETES MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS, LUPUS, ULCERATIVE COLITIS, AND THE TREATMENT OF OTHER DISEASES and CONDITIONS, NAMELY, CANCER, HEMOPHILIA, OSTEOPORSIS, CYSTIC FIBROSIS, ANEMIA, INFERTILITY, GAUCHER'S DISEASE, STUNTED GROWTH, HEPATITIS A, B, AND C, ACUTE MYOCARDIAL INFARCTION, STROKE, RESPIRATORY SYNCYTIAL VIRUS, CROHN'S DISEASE, AND ARTHROSCLEROSIS
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005